Immunosuppression drug advice and COVID-19: are we doing more harm than good?
Br J Hosp Med (Lond)
; 81(6): 1-3, 2020 Jun 02.
Article
in English
| MEDLINE | ID: covidwho-614930
ABSTRACT
The National Institute for Health and Care Excellence guidelines advise stopping immunosuppressive drugs for confirmed or suspected COVID-19 patients with autoimmune and inflammatory disorders. This may not be in the patient's best interest, given the potential long-term consequences of not managing chronic conditions, and immunosuppression may even be protective in those affected with COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Deprescriptions
/
Cytokine Release Syndrome
/
Immunosuppressive Agents
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Br J Hosp Med (Lond)
Journal subject:
Hospitals
/
Medicine
Year:
2020
Document Type:
Article
Affiliation country:
Hmed.2020.0312
Similar
MEDLINE
...
LILACS
LIS